Body Mass Index and Risk of Left Atrial Thrombus in Patients With Atrial Fibrillation

American Journal of Cardiology

Volumn 104, Issue 12, 2009, Pages 1699-1703

  Tang, Ri Bo ^a   Liu, Xiao Hui ^a   Kalifa, Jérôme ^b   Li, Zhi An ^a   Dong, Jian Zeng ^a   Yang, Ya ^a   Liu, Xing Peng ^a   Long, De Yong ^a   Yu, Rong Hui ^a   Ma, Chang Sheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; AGED; AGING; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CATHETER ABLATION; CLINICAL TRIAL; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART FAILURE; HEART LEFT ATRIUM; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ATRIAL FIBRILLATION; BODY MASS INDEX; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART DISEASES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; THROMBOSIS;

EID: 70949095357     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.07.054     Document Type: Article

References (29)

1. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., and Singer D.E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 285 (2001) 2370-2375
2. Tsang T.S., Barnes M.E., Miyasaka Y., Cha S.S., Bailey K.R., Verzosa G.C., Seward J.B., and Gersh B.J. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J 29 (2008) 2227-2233
3. Madala M.C., Franklin B.A., Chen A.Y., Berman A.D., Roe M.T., Peterson E.D., Ohman E.M., Smith Jr. S.C., Gibler W.B., and McCullough P.A. Obesity and age of first non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 52 (2008) 979-985
4. Tang R.B., Dong J.Z., Liu X.P., Long D.Y., Yu R.H., Kalifa J., and Ma C.S. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation. Circ J 73 (2009) 438-443
5. Wanahita N., Messerli F.H., Bangalore S., Gami A.S., Somers V.K., and Steinberg J.S. Atrial fibrillation and obesity-results of a meta-analysis. Am Heart J 155 (2008) 310-315
6. Wang T.J., Parise H., Levy D., D'Agostino Sr. R.B., Wolf P.A., Vasan R.S., and Benjamin E.J. Obesity and the risk of new-onset atrial fibrillation. JAMA 292 (2004) 2471-2477
7. Bowles L.K., Cooper J.A., Howarth D.J., Miller G.J., and MacCallum P.K. Associations of haemostatic variables with body mass index: a community-based study. Blood Coagul Fibrinolysis 14 (2003) 569-573
8. Darvall K.A., Sam R.C., Silverman S.H., Bradbury A.W., and Adam D.J. Obesity and thrombosis. Eur J Vasc Endovasc Surg 33 (2007) 223-233
9. Schnabel R.B., Larson M.G., Yamamoto J.F., Kathiresan S., Rong J., Levy D., Keaney Jr. J.F., Wang T.J., Vasan R.S., and Benjamin E.J. Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol 104 (2009) 92-96
10. Yu C.Y., Lo Y.H., and Chiou W.K. The 3D scanner for measuring body surface area: a simplified calculation in the Chinese adult. Appl Ergon 34 (2003) 273-278
11. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.Y., Kay G.N., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann S., Smith Jr. S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Halperin J.L., Hunt S.A., Nishimura R., Ornato J.P., Page R.L., Riegel B., Priori S.G., Blanc J.J., Budaj A., Camm A.J., Dean V., Deckers J.W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., Tamargo J.L., and Zamorano J.L. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 suppl (2006) e257-e354
12. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith Jr. S.C., Spertus J.A., and Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
13. Lu Y.H., Lu J.M., Wang S.Y., Li C.L., Liu L.S., Zheng R.P., Tian H., Wang X.L., Yang L.J., Zhang Y.Q., and Pan C.Y. Comparison of the diagnostic criteria of metabolic syndrome by international Diabetes Federation and that by Chinese Medical Association Diabetes Branch. Zhonghua Yi Xue Za Zhi 86 (2006) 386-389
14. Genuth S., Alberti K.G., Bennett P., Buse J., Defronzo R., Kahn R., Kitzmiller J., Knowler W.C., Lebovitz H., Lernmark A., Nathan D., Palmer J., Rizza R., Saudek C., Shaw J., Steffes M., Stern M., Tuomilehto J., and Zimmet P. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
15. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
16. Habara S., Dote K., Kato M., Sasaki S., Goto K., Takemoto H., Hasegawa D., and Matsuda O. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 28 (2007) 2217-2222
17. Khan M.N., Usmani A., Noor S., Elayi S., Ching C.K., Di Biase L., Patel D., Burkhardt J.D., Cummings J., Schweikert R., Saliba W., and Natale A. Low incidence of left atrial or left atrial appendage thrombus in patients with paroxysmal atrial fibrillation and normal EF who present for pulmonary vein antrum isolation procedure. J Cardiovasc Electrophysiol 19 (2008) 356-358
18. Kleemann T., Becker T., Strauss M., Schneider S., and Seidl K. Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score. Eur J Echocardiogr 10 (2009) 383-388
19. Scherr D., Dalal D., Chilukuri K., Dong J., Spragg D., Henrikson C.A., Nazarian S., Cheng A., Berger R.D., Abraham T.P., Calkins H., and Marine J.E. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 20 (2009) 379-384
20. Mazouz B., Keren A., and Chenzbraun A. Age alone is not a risk factor for left atrial thrombus in atrial fibrillation. Heart 94 (2008) 197-199
21. Khumri T.M., Idupulapati M., Rader V.J., Nayyar S., Stoner C.N., and Main M.L. Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation. Am J Cardiol 99 (2007) 1733-1736
22. Rader V.J., Khumri T.M., Idupulapati M., Stoner C.N., Magalski A., and Main M.L. Clinical predictors of left atrial thrombus and spontaneous echocardiographic contrast in patients with atrial fibrillation. J Am Soc Echocardiogr 20 (2007) 1181-1185
23. Hu D., and Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. J Am Coll Cardiol 52 (2008) 865-868
24. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22 (1991) 983-988
25. Estes III N.A.M., Halperin J.L., Calkins H., Ezekowitz M.D., Gitman P., Go A.S., McNamara R.L., Messer J.V., Ritchie J.L., Romeo S.J.W., Waldo A.L., Wyse D.G., Bonow R.O., Estes III N.A.M., DeLong E., Goff Jr. D.C., Grady K., Green L.A., Hiniker A., Linderbaum J.A., Masoudi F.A., Pina I.L., Pressler S., Radford M.J., and Rumsfeld J.S. ACC/AHA/physician consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association task force on performance measures and the physician consortium for performance improvement (writing committee to develop clinical performance measures for atrial fibrillation) developed in collaboration with the Heart Rhythm Society. J Am Coll Cardiol 51 (2008) 865-884
26. Eichinger S., Hron G., Bialonczyk C., Hirschl M., Minar E., Wagner O., Heinze G., and Kyrle P.A. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med 168 (2008) 1678-1683
27. Sola E., Vaya A., Corella D., Santaolaria M.L., Espana F., Estelles A., and Hernandez-Mijares A. Erythrocyte hyperaggregation in obesity: determining factors and weight loss influence. Obesity 15 (2007) 2128-2134
28. Rosito G.A., D'Agostino R.B., Massaro J., Lipinska I., Mittleman M.A., Sutherland P., Wilson P.W., Levy D., Muller J.E., and Tofler G.H. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost 91 (2004) 683-689
29. Fang M.C., Go A.S., Chang Y., Borowsky L., Pomernacki N.K., and Singer D.E. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol 51 (2008) 810-815